Drug Resistant TB

Drug-resistant TB: Current Scenario And Treatment Challenges

About Event

Topic:  Drug-resistant TB: Current scenario and treatment challenges

Date: 18th Jun 2022 || Time: 7:00 pm to 8:00 pm

Chief Guest Speaker: Dr. Anchit Bhatnagar, Assistant Professor, Terna Speciality Hospital & Research Centre, Navi Mumbai

Guest Speaker:  Dr. Sowmya Dhawan, Microbiologist Intermediate Reference Laboratory, National Tuberculosis Elimination Programme, National Health Mission, Madhya Pradesh.
Moderator: Dr. Chaitali Nikam, GM, and Head – Infectious Disease Division, FocusTB Thyrocare

Email ID:  [email protected]

In 2020 TB was the 13th leading cause of death globally and Southeast Asia accounted for
43% of all new cases, with almost 500,000 new cases of multi-drug resistant TB (MDR-TB).
It becomes critical to diagnose and initiate the right treatment, especially for drug-resistant
individuals with TB cannot be treated empirically.

Rapid and comprehensive drug resistance testing is the need of the hour and TB-whole genome testing enables that. It is time to usher in a new era of genotypic drug resistance determination.

In this webinar, Dr. Anchit Bhatnagar will share his experience in treating Tb patients and
adoption of whole-genome sequencing for determining drug resistance.